Some content of this application is unavailable at the moment.
If this situation persist, please contact us atFeedback&Contact
1. (AU2014261329) Fenfluramine for use in the treatment of dravet syndrome

Office : Australia
Application Number: 2014261329 Application Date: 01.05.2014
Publication Number: 2014261329 Publication Date: 05.11.2015
Publication Kind : B2
Prior PCT appl.: Application Number:EP2014058954 ; Publication Number: Click to see the data
IPC:
A61K 31/137
A61K 45/06
A61P 25/08
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31
Medicinal preparations containing organic active ingredients
13
Amines, e.g. amantadine
135
having aromatic rings, e.g. methadone
137
Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
45
Medicinal preparations containing active ingredients not provided for in groups A61K31/-A61K41/132
06
Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
P
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
25
Drugs for disorders of the nervous system
08
Antiepileptics; Anticonvulsants
Applicants: Katholieke Universiteit Leuven
University Hospital Antwerp
Inventors:
Agents: Davies Collison Cave Pty Ltd
Priority Data: 13/887,014 03.05.2013 US
Title: (EN) Fenfluramine for use in the treatment of dravet syndrome
Abstract:
(EN) An effective dose of fenfluramine or its pharmaceutically acceptable salt for use in a method of treating and/or preventing Dravet Syndrome in a patient such as a patient previously diagnosed with Dravet Syndrome.
Also published as:
CA2909335EP2991637BR112015027282DK2991637ES2666657EP3329909
PT2991637WO/2014/177676